Reiberger, T <br/><br/>
Concomitant highly active antiretroviral therapy leads to smaller decline and faster recovery of CD4+ cell counts during and after pegylated interferon plus ribavirin therapy in HIV-hepatitis C virus coinfected patients.  [electronic resource] 

 -  The Journal of infectious diseases  Jun 2011 
 - 1802-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-6613 
<br/><br/><label>Standard No.: </label>10.1093/infdis/jir194  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiretroviral Therapy, Highly Active--methods<br/>Antiviral Agents--therapeutic use<br/>CD4 Lymphocyte Count<br/>CD4-Positive T-Lymphocytes--drug effects<br/>Drug Therapy, Combination<br/>Female<br/>HIV Infections--complications<br/>Hepatitis C--complications<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--therapeutic use<br/>Recombinant Proteins<br/>Ribavirin--therapeutic use<br/>Treatment Outcome